Biofrontera Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was USD 0.011 million compared to USD 0.018 million a year ago. Revenue was USD 7.91 million compared to USD 8.73 million a year ago.

Net loss was USD 10.44 million compared to USD 7.48 million a year ago. Basic loss per share from continuing operations was USD 2.88 compared to USD 5.6 a year ago.